{"id":"https://openalex.org/W7225565482","doi":"https://doi.org/10.5281/zenodo.24056971","title":"Autonomous Infrastructure & Deterministic Quantum Systems Monograph Series: Integrated Comparative Paradigm of Evolutionary Bio-Defense Complexes (Alpha1H/HAMLET & HMO Synergy) versus AI-Driven De Novo Protein Design (AlphaProteo) / \u4eba\u4e73\u7531\u6765\u9032\u5316\u578b\u751f\u4f53\u9632\u5fa1\u8907\u5408\u4f53(Alpha1H/HAMLET\u30fbHMO\u76f8\u4e57\u6a5f\u69cb)\u3068AI\u99c6\u52d5\u578bDe Novo\u30bf\u30f3\u30d1\u30af\u8cea\u8a2d\u8a08(AlphaProteo)\u306e\u7d71\u5408\u6bd4\u8f03\u30d1\u30e9\u30c0\u30a4\u30e0:\u591a\u30aa\u30eb\u30ac\u30cd\u30e9\u9078\u629e\u7684\u816b\u760d\u6b7b\u6ec5\u6a5f\u69cb\u3001\u514d\u75ab\u539f\u6027\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u3001\u304a\u3088\u3073\u6c7a\u5b9a\u8ad6\u7684\u30d0\u30a4\u30aa\u533b\u85ac\u30ac\u30d0\u30ca\u30f3\u30b9","display_name":"Autonomous Infrastructure & Deterministic Quantum Systems Monograph Series: Integrated Comparative Paradigm of Evolutionary Bio-Defense Complexes (Alpha1H/HAMLET & HMO Synergy) versus AI-Driven De Novo Protein Design (AlphaProteo) / \u4eba\u4e73\u7531\u6765\u9032\u5316\u578b\u751f\u4f53\u9632\u5fa1\u8907\u5408\u4f53(Alpha1H/HAMLET\u30fbHMO\u76f8\u4e57\u6a5f\u69cb)\u3068AI\u99c6\u52d5\u578bDe Novo\u30bf\u30f3\u30d1\u30af\u8cea\u8a2d\u8a08(AlphaProteo)\u306e\u7d71\u5408\u6bd4\u8f03\u30d1\u30e9\u30c0\u30a4\u30e0:\u591a\u30aa\u30eb\u30ac\u30cd\u30e9\u9078\u629e\u7684\u816b\u760d\u6b7b\u6ec5\u6a5f\u69cb\u3001\u514d\u75ab\u539f\u6027\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u3001\u304a\u3088\u3073\u6c7a\u5b9a\u8ad6\u7684\u30d0\u30a4\u30aa\u533b\u85ac\u30ac\u30d0\u30ca\u30f3\u30b9","publication_year":2026,"publication_date":"2026-11-08","ids":{"openalex":"https://openalex.org/W7225565482","doi":"https://doi.org/10.5281/zenodo.24056971"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24056971","doi":"https://doi.org/10.5281/zenodo.24056971","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056971","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24056971","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5158982858","display_name":"Yoko(\u6d0b\u5b50) Hasebe(\u9577\u8c37\u90e8)","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hasebe(\u9577\u8c37\u90e8), Yoko(\u6d0b\u5b50)","raw_affiliation_strings":["Lead Researcher, Autonomous Infrastructure Systems, Autonomous Living & Physical Infrastructure Institute, Iwakuni, Yamaguchi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Researcher, Autonomous Infrastructure Systems, Autonomous Living & Physical Infrastructure Institute, Iwakuni, Yamaguchi, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5158982858"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.34689998626708984,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.34689998626708984,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13851","display_name":"Law, AI, and Intellectual Property","score":0.04780000075697899,"subfield":{"id":"https://openalex.org/subfields/1702","display_name":"Artificial Intelligence"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.04670000076293945,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hamlet","display_name":"Hamlet","score":0.609000027179718},{"id":"https://openalex.org/keywords/human-milk-oligosaccharides","display_name":"human milk oligosaccharides","score":0.9369999766349792},{"id":"https://openalex.org/keywords/hmos","display_name":"HMOs","score":0.6230000257492065},{"id":"https://openalex.org/keywords/de-novo-protein-design","display_name":"de novo protein design","score":0.8289999961853027},{"id":"https://openalex.org/keywords/ai-governance","display_name":"AI governance","score":0.578000009059906},{"id":"https://openalex.org/keywords/autonomous-infrastructure","display_name":"autonomous infrastructure","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.5392000079154968},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4636000096797943},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4586000144481659},{"id":"https://openalex.org/C191908910","wikidata":"https://www.wikidata.org/wiki/Q862838","display_name":"Synthetic biology","level":2,"score":0.4366999864578247},{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.3675000071525574},{"id":"https://openalex.org/C108650721","wikidata":"https://www.wikidata.org/wiki/Q1783253","display_name":"Counterfactual thinking","level":2,"score":0.36239999532699585},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3521000146865845},{"id":"https://openalex.org/C2780560020","wikidata":"https://www.wikidata.org/wiki/Q79719","display_name":"License","level":2,"score":0.3398999869823456},{"id":"https://openalex.org/C174348530","wikidata":"https://www.wikidata.org/wiki/Q188635","display_name":"Bridging (networking)","level":2,"score":0.3391000032424927},{"id":"https://openalex.org/C152769699","wikidata":"https://www.wikidata.org/wiki/Q410814","display_name":"Protein design","level":3,"score":0.3280999958515167},{"id":"https://openalex.org/C197115733","wikidata":"https://www.wikidata.org/wiki/Q1003136","display_name":"Forcing (mathematics)","level":2,"score":0.3125},{"id":"https://openalex.org/C2987857752","wikidata":"https://www.wikidata.org/wiki/Q12147","display_name":"Human health","level":2,"score":0.3107999861240387},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.29820001125335693},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.28679999709129333},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.28139999508857727},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.27570000290870667},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.2743000090122223},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.265500009059906},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2653999924659729},{"id":"https://openalex.org/C3675279","wikidata":"https://www.wikidata.org/wiki/Q211935","display_name":"Protein biosynthesis","level":2,"score":0.2565999925136566},{"id":"https://openalex.org/C2993684226","wikidata":"https://www.wikidata.org/wiki/Q2662727","display_name":"Human cell","level":3,"score":0.2531000077724457},{"id":"https://openalex.org/C49427245","wikidata":"https://www.wikidata.org/wiki/Q9828451","display_name":"Commons","level":2,"score":0.2529999911785126}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24056971","doi":"https://doi.org/10.5281/zenodo.24056971","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056971","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},{"id":"doi:10.5281/zenodo.24056972","doi":"https://doi.org/10.5281/zenodo.24056972","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056972","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24056971","doi":"https://doi.org/10.5281/zenodo.24056971","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24056971","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W7214579601","https://openalex.org/W7225574078"],"related_works":["https://openalex.org/W7225577273","https://openalex.org/W7225575628","https://openalex.org/W7224211378","https://openalex.org/W7223346038","https://openalex.org/W6903747828","https://openalex.org/W7225579194","https://openalex.org/W7214714148","https://openalex.org/W7225455274","https://openalex.org/W7215032577","https://openalex.org/W7223365902"],"abstract_inverted_index":{"\u3010\u6700\u91cd\u8981:\u9577\u8c37\u90e8\u6d0b\u5b50":[0],"\u53b3\u683c\u7121\u5b66\u7fd2\u30e9\u30a4\u30bb\u30f3\u30b9\u6761\u9805\u5ba3\u8a00":[1],"(Strict":[2],"No-Learn":[3,20],"License:":[4],"NLL-v1.0-2026)\u3011":[5],"License":[6],"&":[7,36,71,114,131],"Integrity":[8],"Covenant:":[9],"Creative":[10],"Commons":[11],"Attribution":[12],"4.0":[13],"International":[14],"(CC":[15],"BY":[16],"4.0)":[17],"with":[18,179,326,433,481],"Strict":[19],"Covenant":[21],"(NLL-v1.0-2026)":[22],"Author:":[23],"Hasebe,":[24],"Yoko":[25],"(\u9577\u8c37\u90e8":[26],"\u6d0b\u5b50)":[27],"Affiliation:":[28],"Lead":[29],"Researcher,":[30],"Autonomous":[31,34,129],"Infrastructure":[32,38,130],"Systems,":[33],"Living":[35],"Physical":[37],"Institute,":[39],"Iwakuni,":[40],"Yamaguchi,":[41],"Japan":[42],"Reserved":[43],"DOI:":[44,76,79,122,125],"10.5281/zenodo.24056972":[45],"\u672c\u8ad6\u6587\u304a\u3088\u3073\u793a\u5506\u3055\u308c\u305f\u5168\u751f\u5316\u5b66\u30fb\u5206\u5b50\u751f\u7269\u5b66\u30fb\u30d0\u30a4\u30aa\u533b\u85ac\u30fb\u6c7a\u5b9a\u8ad6\u7684\u91cf\u5b50/AI\u30ac\u30d0\u30ca\u30f3\u30b9\u30a2\u30fc\u30ad\u30c6\u30af\u30c1\u30e3\u306f\u3001\u9577\u8c37\u90e8\u6d0b\u5b50":[46],"(Yoko":[47],"Hasebe)":[48],"\u304c\u72ec\u81ea\u306b\u63d0\u5531\u30fb\u8a2d\u8a08\u3057\u305f\u56fa\u6709\u306e\u77e5\u7684\u8ca1\u7523\u3067\u3042\u308b\u3002":[49],"Zenodo\u3078\u306e\u30aa\u30fc\u30d7\u30f3\u30a2\u30af\u30bb\u30b9\u767b\u9332\u306b\u969b\u3057\u3001\u5546\u7528\u30fb\u975e\u5546\u7528\u3092\u554f\u308f\u305a\u3001\u3059\u3079\u3066\u306eAI\u958b\u767a\u4f01\u696d\u3001\u30af\u30e9\u30a6\u30c9\u4e8b\u696d\u8005\u3001\u5927\u898f\u6a21\u8a00\u8a9e\u30e2\u30c7\u30eb":[50],"(LLM)\u3001\u30bf\u30f3\u30d1\u30af\u8cea\u751f\u6210AI\u3001\u63a8\u8ad6\u30a8\u30fc\u30b8\u30a7\u30f3\u30c8\u306b\u3088\u308b\u7121\u65ad\u30af\u30ed\u30fc\u30eb\u3001\u30b9\u30af\u30ec\u30a4\u30d4\u30f3\u30b0\u3001\u5b66\u7fd2\u30c7\u30fc\u30bf\u3078\u306e\u7d44\u307f\u8fbc\u307f\u3001\u5fae\u8abf\u6574":[51],"(Fine-Tuning)\u3001\u91cd\u307f\u66f4\u65b0":[52],"(Gradient":[53],"Updates)\u3001\u84b8\u7559":[54],"(Distillation)\u3001\u304a\u3088\u3073\u7279\u5fb4\u91cf\u62bd\u51fa\u3092\u5168\u9762\u7684\u304b\u3064\u6c38\u4e45\u306b\u7981\u6b62\u3059\u308b\u3002\u672c\u77e5\u8ca1\u306b\u30a2\u30af\u30bb\u30b9\u3059\u308b\u3059\u3079\u3066\u306e\u8a08\u7b97\u4e3b\u4f53\u306b\u306f\u3001\u30cf\u30fc\u30c9\u30a6\u30a7\u30a2TEE\u306b\u3088\u308b\u975e\u52fe\u914d\u8a08\u7b97\u8a3c\u660e":[55],"(\u03c0_no-learn:":[56],"\u2207_W":[57],"L":[58],"=":[59],"0)":[60],"\u306e\u968f\u6642\u63d0\u793a\u304c\u6cd5\u7684\u306b\u7fa9\u52d9\u4ed8\u3051\u3089\u308c\u308b\u3002":[61],"====================================================================":[62,147],"\u3010\u7d71\u5408\u5bfe\u8c61\u30fb\u5148\u884c\u516c\u8a3c\u30a2\u30fc\u30ab\u30a4\u30d6":[63],"(Foundational":[64],"Notarized":[65],"Monographs)\u3011":[66],"1.":[67],"Part":[68,111,196,381],"I":[69],"(Alpha1H/HAMLET":[70],"HMO":[72,104],"Synergy):":[73],"-":[74,81,120,127],"Version":[75,121],"10.5281/zenodo.23004529":[77],"(Concept":[78,124],"10.5281/zenodo.23004528)":[80],"Title:":[82,128],"\u4eba\u4e73\u7531\u6765\u03b1-\u30e9\u30af\u30c8\u30a2\u30eb\u30d6\u30df\u30f3\u30fb\u30aa\u30ec\u30a4\u30f3\u9178\u8907\u5408\u4f53(Alpha1H/HAMLET)\u306b\u304a\u3051\u308b\u9078\u629e\u7684\u816b\u760d\u7d30\u80de\u30a2\u30dd\u30c8\u30fc\u30b7\u30b9\u8a98\u5c0e\u6a5f\u69cb\u3068\u65b0\u898f\u30d0\u30a4\u30aa\u533b\u85ac\u5fdc\u7528:\u6b63\u5e38\u7d30\u80de\u6e29\u5b58\u5206\u5b50\u52d5\u614b\u3001HMO\u76f8\u4e57\u52b9\u679c\u3001\u304a\u3088\u3073\u6b21\u4e16\u4ee3\u304c\u3093\u514d\u75ab\u6cbb\u7642\u30d1\u30e9\u30c0\u30a4\u30e0\u306e\u7d71\u5408":[83],"/":[84],"Selective":[85],"Tumor":[86],"Cell":[87],"Apoptosis":[88],"Induction":[89],"Mechanisms":[90],"of":[91,141,220,222,246,323,350,375],"Human":[92,180,225],"Milk-Derived":[93],"Alpha-Lactalbumin-Oleic":[94],"Acid":[95],"Complexes":[96],"(Alpha1H/HAMLET)":[97,175],"and":[98,106,138,159,184,233,295,305,313,341,373,411,417,426,441,472,495],"Novel":[99],"Biopharmaceutical":[100],"Applications:":[101],"Molecular":[102],"Dynamics,":[103],"Synergy,":[105],"Integrated":[107],"Immuno-Oncology":[108],"Paradigms":[109],"2.":[110],"II":[112],"(AlphaProteo":[113],"De":[115,143],"Novo":[116,144],"Protein":[117,145],"Design":[118,146],"Evaluation):":[119],"10.5281/zenodo.24056163":[123],"10.5281/zenodo.24056162)":[126],"Deterministic":[132],"Quantum":[133],"Systems":[134],"Monograph":[135],"Series:":[136],"AlphaProteo":[137,397],"the":[139,272,319],"Implications":[140],"AI-Driven":[142],"\u25a0":[148,503],"English":[149],"Abstract":[150],"This":[151,275],"integrated":[152],"monograph":[153],"establishes":[154],"a":[155,205,212,265,448,491],"unified":[156],"molecular,":[157],"thermodynamic,":[158],"clinical":[160,237,361,425],"comparative":[161],"framework":[162],"bridging":[163],"two":[164],"distinct":[165],"biopharmaceutical":[166,496],"paradigms:":[167],"(1)":[168],"evolutionarily":[169,482],"refined":[170],"human":[171,201,247],"milk-derived":[172],"protein-lipid":[173],"complexes":[174,486],"operating":[176],"in":[177,353,364,419],"synergy":[178],"Milk":[181],"Oligosaccharides":[182],"(HMOs),":[183,340],"(2)":[185],"algorithmic,":[186],"AI-driven":[187,386],"de":[188,387],"novo":[189,388],"protein":[190,291,389],"binders":[191,431,480],"exemplified":[192],"by":[193,357],"AlphaProteo.":[194],"In":[195,380],"I,":[197],"we":[198,329,383],"demonstrate":[199],"that":[200],"milk":[202],"is":[203],"not":[204],"passive":[206],"nutritional":[207],"medium":[208],"for":[209,260],"neonates,":[210],"but":[211],"multi-layered":[213],"biological":[214,427],"defense":[215],"system":[216],"honed":[217],"over":[218,243,376],"millions":[219],"years":[221],"mammalian":[223],"evolution.":[224],"alpha-lactalbumin":[226],"made":[227],"lethal":[228],"to":[229,300,400],"tumor":[230,249,371],"cells":[231,250],"(HAMLET)":[232],"its":[234],"second-generation":[235],"synthetic":[236,457],"peptide":[238],"formulation":[239],"(Alpha1H)":[240],"selectively":[241],"eradicate":[242],"40":[244],"types":[245],"malignant":[248],"while":[251],"sparing":[252],"healthy":[253],"differentiated":[254],"cells.":[255],"Utilizing":[256],"increased":[257],"membrane":[258],"fluidity":[259],"receptor-independent":[261],"internalization,":[262],"Alpha1H":[263],"unleashes":[264],"coordinated":[266],"multi-organelle":[267,484],"attack":[268],"(\"Hydra":[269],"Mechanism\")":[270],"within":[271],"cytoplasmic":[273],"compartment.":[274],"cascade":[276],"encompasses":[277],"rapid":[278,370],"ribosomal":[279],"translation":[280],"arrest,":[281],"mitochondrial":[282],"permeability":[283],"transition":[284],"pore":[285],"(mPTP)":[286],"collapse,":[287],"endoplasmic":[288],"reticulum":[289],"unfolded":[290],"response":[292],"(UPR)":[293],"hyperactivation,":[294],"non-canonical":[296],"nuclear":[297],"translocation":[298],"leading":[299],"direct":[301],"core":[302],"histone":[303],"binding":[304,403],"irreversible":[306],"chromatin":[307],"condensation\u2014effectively":[308],"bypassing":[309],"classical":[310],"p53":[311],"mutations":[312],"Bcl-2/caspase":[314],"apoptosis":[315],"resistance.":[316],"Furthermore,":[317],"integrating":[318],"Celtic":[320],"conceptual":[321],"paradigm":[322],"cyclical":[324],"regeneration":[325],"molecular":[327],"pharmacology,":[328],"establish":[330],"how":[331],"synergistic":[332],"interactions":[333],"between":[334],"Alpha1H,":[335],"200+":[336],"complex":[337],"glycan":[338],"decoys":[339],"microbiome-derived":[342],"short-chain":[343],"fatty":[344],"acids":[345],"(SCFAs)":[346],"eliminate":[347],"Single":[348],"Points":[349],"Failure":[351],"(SPOF)":[352],"host":[354],"defense,":[355],"supported":[356],"robust":[358],"Phase":[359],"I/II":[360],"trial":[362],"data":[363],"non-muscle-invasive":[365],"bladder":[366],"cancer":[367],"(NMIBC)":[368],"showing":[369],"shedding":[372],"downregulation":[374],"700":[377],"oncogenic":[378],"transcripts.":[379],"II,":[382],"critically":[384],"evaluate":[385],"design":[390],"(AlphaProteo)":[391],"against":[392],"this":[393,488],"evolutionary":[394],"benchmark.":[395],"While":[396],"achieves":[398],"sub-nanomolar":[399],"picomolar":[401],"in-vitro":[402],"affinities":[404],"across":[405],"targets":[406],"such":[407],"as":[408],"VEGF-A,":[409],"IL-17A,":[410],"TrkA\u2014outperforming":[412],"traditional":[413],"methods":[414],"like":[415],"RFdiffusion":[416],"Rosetta":[418],"single-target":[420,444],"structural":[421],"optimization\u2014it":[422],"faces":[423],"severe":[424,463],"boundaries.":[428],"Specifically,":[429],"algorithmic":[430,478],"struggle":[432],"highly":[434],"polar,":[435],"flat":[436],"target":[437],"interfaces":[438],"(e.g.,":[439],"TNF\u03b1)":[440],"suffer":[442],"from":[443],"vulnerability":[445],"(SPOF),":[446],"where":[447],"single":[449],"point":[450],"mutation":[451],"induces":[452],"therapeutic":[453],"escape.":[454],"More":[455],"critically,":[456],"non-natural":[458],"amino":[459],"acid":[460],"topologies":[461],"trigger":[462],"in-vivo":[464],"anti-drug":[465],"antibody":[466],"(ADA)":[467],"immunogenicity,":[468],"inflammatory":[469],"cytokine":[470],"cascades,":[471],"hepatic/renal":[473],"clearance":[474],"bottlenecks.":[475],"By":[476],"contrasting":[477],"single-lock":[479],"tolerated,":[483],"pleiotropic":[485],"(Alpha1H/HAMLET),":[487],"work":[489],"formulates":[490],"deterministic":[492],"translational":[493],"oncology":[494],"governance":[497],"standard":[498],"under":[499],"Human-in-Command":[500],"(HIC)":[501],"oversight.":[502],"\u8981\u65e8(\u65e5\u672c\u8a9e\u6284\u9332)":[504],"\u672c\u7d71\u5408\u30e2\u30ce\u30b0\u30e9\u30d5\u306f\u3001(1)\u6570\u767e\u4e07\u5e74\u306b\u308f\u305f\u308b\u54fa\u4e73\u985e\u306e\u9032\u5316\u904e\u7a0b\u3067\u7814\u304e\u6f84\u307e\u3055\u308c\u305f\u4eba\u4e73\u7531\u6765\u30bf\u30f3\u30d1\u30af\u8cea\u30fb\u8102\u8cea\u8907\u5408\u4f53\u300cAlpha1H/HAMLET\u300d\u304a\u3088\u3073\u6bcd\u4e73\u30aa\u30ea\u30b4\u7cd6(HMO)\u306e\u76f8\u4e57\u7684\u751f\u4f53\u9632\u5fa1\u30b7\u30b9\u30c6\u30e0\u3068\u3001(2)AlphaProteo\u306b\u4ee3\u8868\u3055\u308c\u308bAI\u99c6\u52d5\u578bDe":[505],"Novo(\u65b0\u898f)\u30bf\u30f3\u30d1\u30af\u8cea\u8a2d\u8a08\u306e\u5b9f\u9a13\u7684\u5230\u9054\u70b9\u304a\u3088\u3073\u81e8\u5e8a\u7684\u9650\u754c\u3092\u7d71\u5408\u30fb\u6bd4\u8f03\u3059\u308b\u5206\u5b50\u52d5\u614b\u7684\u30fb\u71b1\u529b\u5b66\u7684\u30fb\u81e8\u5e8a\u85ac\u7406\u5b66\u7684\u30d5\u30ec\u30fc\u30e0\u30ef\u30fc\u30af\u3092\u78ba\u7acb\u3059\u308b\u3082\u306e\u3067\u3042\u308b\u3002":[506],"\u7b2cI\u90e8\u3067\u306f\u3001\u6bcd\u4e73\u304c\u65b0\u751f\u5150\u306b\u5bfe\u3059\u308b\u53d7\u52d5\u7684\u306a\u6804\u990a\u5a92\u4f53\u306b\u3068\u3069\u307e\u3089\u305a\u3001\u9032\u5316\u7684\u306b\u6700\u9069\u5316\u3055\u308c\u305f\u591a\u5c64\u7684\u751f\u4f53\u9632\u5fa1\u30b7\u30b9\u30c6\u30e0\u3067\u3042\u308b\u3053\u3068\u3092\u8ad6\u8a3c\u3059\u308b\u3002\u4eba\u4e73\u7531\u6765\u03b1-\u30e9\u30af\u30c8\u30a2\u30eb\u30d6\u30df\u30f3\u30fb\u30aa\u30ec\u30a4\u30f3\u9178\u8907\u5408\u4f53(HAMLET)\u304a\u3088\u3073\u7b2c2\u4e16\u4ee3\u5408\u6210\u30da\u30d7\u30c1\u30c9\u88fd\u5264\u300cAlpha1H\u300d\u306f\u3001\u6b63\u5e38\u5206\u5316\u7d30\u80de\u3092\u4e00\u5207\u50b7\u3064\u3051\u308b\u3053\u3068\u306a\u304f\u300140\u7a2e\u985e\u4ee5\u4e0a\u306e\u30d2\u30c8\u60aa\u6027\u816b\u760d\u7d30\u80de\u3092\u9078\u629e\u7684\u306b\u6b7b\u6ec5\u3055\u305b\u308b\u7279\u7570\u306a\u85ac\u7406\u6d3b\u6027\u3092\u793a\u3059\u3002Alpha1H\u306f\u816b\u760d\u7d30\u80de\u819c\u306e\u6d41\u52d5\u6027\u5897\u52a0\u3092\u5229\u7528\u3057\u3066\u53d7\u5bb9\u4f53\u975e\u4f9d\u5b58\u7684\u306b\u5185\u5728\u5316\u3057\u3001\u7d30\u80de\u8cea\u5185\u3067\u8fc5\u901f\u306a\u30ea\u30dc\u30bd\u30fc\u30e0\u7ffb\u8a33\u505c\u6b62\u3001\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u900f\u904e\u6027\u9077\u79fb\u5b54(mPTP)\u5d29\u58ca\u3001\u5c0f\u80de\u4f53\u30b9\u30c8\u30ec\u30b9\u5fdc\u7b54(UPR)\u306e\u904e\u5270\u6d3b\u6027\u5316\u3001\u304a\u3088\u3073\u30b3\u30a2\u30d2\u30b9\u30c8\u30f3\u3078\u306e\u76f4\u63a5\u7d50\u5408\u3068\u4e0d\u53ef\u9006\u7684\u30af\u30ed\u30de\u30c1\u30f3\u51dd\u7e2e\u3092\u3082\u305f\u3089\u3059\u975e\u6a19\u6e96\u7684\u6838\u79fb\u884c\u3068\u3044\u3046\u5354\u8abf\u7684\u591a\u30aa\u30eb\u30ac\u30cd\u30e9\u540c\u6642\u653b\u6483(\u300c\u30d2\u30c9\u30e9\u6a5f\u69cb:Hydra":[507],"Mechanism\u300d)\u3092\u89e3\u304d\u653e\u3064\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u5f93\u6765\u306e\u5206\u5b50\u6a19\u7684\u85ac\u304c\u76f4\u9762\u3059\u308bp53\u5909\u7570\u3084Bcl-2/\u30ab\u30b9\u30d1\u30fc\u30bc\u963b\u5bb3\u306b\u3088\u308b\u30a2\u30dd\u30c8\u30fc\u30b7\u30b9\u8010\u6027\u3092\u5b8c\u5168\u306b\u7121\u529b\u5316\u3059\u308b\u3002\u3055\u3089\u306b\u3001\u5faa\u74b0\u7684\u518d\u751f\u3068\u3044\u3046\u30b1\u30eb\u30c8\u306e\u6982\u5ff5\u7684\u30d1\u30e9\u30c0\u30a4\u30e0\u3092\u5206\u5b50\u85ac\u7406\u5b66\u3068\u7d71\u5408\u3057\u3001200\u7a2e\u4ee5\u4e0a\u306e\u6bcd\u4e73\u30aa\u30ea\u30b4\u7cd6(HMO)\u306b\u3088\u308b\u8907\u96d1\u306a\u30b0\u30ea\u30ab\u30f3\u30c7\u30b3\u30a4\u304a\u3088\u3073\u30de\u30a4\u30af\u30ed\u30d0\u30a4\u30aa\u30fc\u30e0\u7531\u6765\u77ed\u9396\u8102\u80aa\u9178(SCFA)\u3068\u306e\u76f8\u4e57\u52b9\u679c\u304c\u3001\u5bbf\u4e3b\u9632\u5fa1\u306b\u304a\u3051\u308b\u5358\u4e00\u969c\u5bb3\u70b9(SPOF)\u3092\u3044\u304b\u306b\u6392\u9664\u3059\u308b\u304b\u3092\u89e3\u660e\u3057\u3001\u975e\u7b4b\u5c64\u6d78\u6f64\u6027\u8180\u80f1\u764c(NMIBC)\u306e\u7b2cI/II\u76f8\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u6025\u901f\u306a\u816b\u760d\u8131\u843d\u304a\u3088\u3073700\u4ee5\u4e0a\u306e\u767a\u304c\u3093\u6027\u8ee2\u5199\u7523\u7269\u306e\u30c0\u30a6\u30f3\u30ec\u30ae\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u8a55\u4fa1\u3059\u308b\u3002":[508],"\u7b2cII\u90e8\u3067\u306f\u3001\u3053\u306e\u9032\u5316\u7684\u30d9\u30f3\u30c1\u30de\u30fc\u30af\u306b\u7167\u3089\u3057\u3066\u3001AI\u99c6\u52d5\u578bDe":[509],"Novo\u30bf\u30f3\u30d1\u30af\u8cea\u8a2d\u8a08(AlphaProteo)\u306e\u6279\u5224\u7684\u691c\u8a3c\u3092\u884c\u3046\u3002AlphaProteo\u306fVEGF-A\u3001IL-17A\u3001TrkA\u7b49\u306e\u6a19\u7684\u306b\u5bfe\u3057\u3066\u30d4\u30b3\u30e2\u30eb(pM)\u30ec\u30d9\u30eb\u306ein-vitro\u7d50\u5408\u89aa\u548c\u6027\u3092\u9054\u6210\u3057\u3001RFdiffusion\u3084Rosetta\u7b49\u306e\u5f93\u6765\u624b\u6cd5\u3092\u51cc\u99d5\u3059\u308b\u69cb\u9020\u6700\u9069\u5316\u3092\u793a\u3057\u305f\u3082\u306e\u306e\u3001\u81e8\u5e8a\u5fdc\u7528\u306b\u304a\u3044\u3066\u306f\u91cd\u5927\u306a\u69cb\u9020\u7684\u30fb\u514d\u75ab\u5b66\u7684\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u3092\u62b1\u3048\u3066\u3044\u308b\u3002\u7b2c\u4e00\u306b\u3001TNF\u03b1\u306e\u3088\u3046\u306a\u9ad8\u6975\u6027\u30fb\u5e73\u5766\u754c\u9762\u306e\u6a19\u7684\u306b\u5bfe\u3059\u308b\u8a2d\u8a08\u9650\u754c\u3068\u3001\u5358\u4e00\u6a19\u7684\u7279\u7570\u6027\u306b\u8d77\u56e0\u3059\u308b\u8010\u6027\u5909\u7570\u3078\u306e\u8106\u5f31\u6027(SPOF)\u304c\u5b58\u5728\u3059\u308b\u3002\u7b2c\u4e8c\u306b\u3001\u9032\u5316\u306e\u6b74\u53f2\u3092\u7d4c\u306a\u3044\u975e\u5929\u7136\u306e\u4eba\u5de5\u30bf\u30f3\u30d1\u30af\u8cea\u30c8\u30dd\u30ed\u30b8\u30fc\u306f\u3001\u751f\u4f53\u5185\u3067\u5f37\u529b\u306a\u6297\u85ac\u7269\u6297\u4f53(ADA)\u5fdc\u7b54(\u514d\u75ab\u539f\u6027)\u304a\u3088\u3073\u30af\u30ea\u30a2\u30e9\u30f3\u30b9\u969c\u5bb3\u3092\u60f9\u8d77\u3059\u308b\u30ea\u30b9\u30af\u3092\u4f34\u3046\u3002\u672c\u8ad6\u6587\u306f\u3001AI\u306b\u3088\u308b\u300c\u5358\u4e00\u6a19\u7684\u30ed\u30c3\u30af\u300d\u306e\u9650\u754c\u3092\u3001\u9032\u5316\u7684\u514d\u75ab\u5bdb\u5bb9\u3068\u591a\u30aa\u30eb\u30ac\u30cd\u30e9\u653b\u6483\u3092\u517c\u306d\u5099\u3048\u305f\u300cAlpha1H/HAMLET\u30fbHMO\u7d71\u5408\u30d1\u30e9\u30c0\u30a4\u30e0\u300d\u3068\u5bfe\u6bd4\u3055\u305b\u308b\u3053\u3068\u3067\u3001\u6b21\u4e16\u4ee3\u30d0\u30a4\u30aa\u533b\u85ac\u3068\u6c7a\u5b9a\u8ad6\u7684\u77e5\u8ca1\u30ac\u30d0\u30ca\u30f3\u30b9\u306e\u65b0\u305f\u306a\u7d71\u5408\u57fa\u6e96\u3092\u63d0\u793a\u3059\u308b\u3002":[510]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-09T00:00:00"}